Clinical Trial Update: Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the combination of cisplatin and irinotecan in patients with fallopian tube, ovarian, or primary peritoneal cancer; the study has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Irinotecan (Irinotecan)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 2 | Status: COMPLETED